These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1942987)

  • 1. [Thromboxane, prostacyclin and platelet factor 4 in patients with atrial fibrillation].
    Panchenko VM; Smoliar MI; Zhivoderov VM
    Klin Med (Mosk); 1991 Jul; 69(7):80-2. PubMed ID: 1942987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
    Lorenzoni R; Lazzerini G; Cocci F; De Caterina R
    Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of chronic atrial fibrillation].
    Gosselink AT
    Tijdschr Gerontol Geriatr; 1995 Dec; 26(6):259-63. PubMed ID: 8553436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [6-keto-prostaglandin F1 alpha and thromboxane B2 in the amniotic fluid and peripheral venous blood in healthy pregnant patients and in pregnant patients with pre-eclampsia].
    Nieder J; Augustin W
    Zentralbl Gynakol; 1987; 109(23):1422-7. PubMed ID: 3442151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for cardioversion of atrial fibrillation.
    El Gendi H; Ismail T; Charalampos K; Mayet J
    Minerva Cardioangiol; 2002 Feb; 50(1):43-52. PubMed ID: 11830718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
    Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
    Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation: preventing thromboembolism and choosing nondrug therapies.
    Chandramouli BV; Kotler MN
    Geriatrics; 1998 Jul; 53(7):53-60. PubMed ID: 9672497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
    Middlekauff HR; Stevenson WG; Gornbein JA
    Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migraine--a haematological disorder?
    Malý J; Pecka M; Krajiickova D; Siroký O; Jebavý L; Bláha M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):105-6. PubMed ID: 8685625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
    Thibault B; Talajic M; Dubuc M; Guerra P; Gagné P; Roy D; Connolly S;
    Can J Cardiol; 2004 Feb; 20(2):195-9. PubMed ID: 15010743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of chuan-xiong granules on platelet aggregation, plasma beta-thromboglobulin, platelet factor IV, thromboxane B2 and 6-keto-prostaglandin F1 alpha in coronary disease patients].
    Yu Z; Chen KJ
    Zhong Xi Yi Jie He Za Zhi; 1987 Jan; 7(1):8-11, 3. PubMed ID: 2954711
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
    King DE; Dickerson LM; Sack JL
    Am Fam Physician; 2002 Jul; 66(2):261-4. PubMed ID: 12152961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation.
    Wozakowska-Kapłon B
    Am J Cardiol; 2004 Jun; 93(12):1555-8. PubMed ID: 15194036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma thromboxane B2 and capacity of the aorta to produce prostacyclin in arteriopathies of the lower extremities].
    Jouve R; Rolland PH; Pellegrin E; Mercier C; Delboy C; Serradimigni A
    J Mal Vasc; 1983; 8(3):221-5. PubMed ID: 6355348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic changes after cardioversion of chronic atrial fibrillation.
    Upshaw CB
    Arch Intern Med; 1997 May; 157(10):1070-6. PubMed ID: 9164372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical challenge of the atrial fibrillation].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2007; 124(2):361-78. PubMed ID: 18069601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation: goals of therapy and management strategies to achieve the goals.
    Padanilam BJ; Prystowsky EN
    Med Clin North Am; 2008 Jan; 92(1):217-35, xii-xiii. PubMed ID: 18061006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.